GETAID retweeted
The first day of 5 Nations ended with a bang! A taste of port wine on a cellar and a rooftop dinner! Today the work continues with discussions about topics like IBD diagnosis, ultrasound or disease monitoring 💪💪💪#5NationsMeetinginIBD
GETAID retweeted
5 Nations is going to start….
Looking forward to be in Porto and start one of the best IBD advanced courses for young IBD fellows. @GEDII_IBD @IGIBD1 @geteccu @PGetaid #israeliIBDsociety
GETAID retweeted
Informative collaborative study between @PGetaid and LYSA.
"Lymphoma In Patients With Inflammatory Bowel Disease: A Multicenter Collaborative Study Between Getaid And Lysa" pubmed.ncbi.nlm.nih.gov/3785…
GETAID retweeted
We are thrilled to announce the publication in @JCC_IBD of 🇫🇷 nationwide study by @PGetaid Surgery Group, comparing the effectiveness of KONO-S versus conventional anastomosis in CD.
academic.oup.com/ecco-jcc/ar…
@jeremielefevre @SWexner @AntoninoSpin @Bealoquebea
GETAID retweeted
Replying to @jeremielefevre
@jeremielefevre presenting the @PGetaid Crohn’s disease post operative cohort : no protective effect of the Kono-S method.
Randomised controlled study is ongoing
#UEGWeek2023
@HopSaintAntoine
@FaculteSanteSU
GETAID retweeted
Chers amis gastro, nous avons besoin de vous !
Le GETAID lance ICARE II
▶️évaluer en vie réelle la tolérance des nouveaux traitements des MICI
▶️ Tous les gastroentérologues en France peuvent participer
✅ Concept du patient chercheur
Inscription lien ou MP
GETAID retweeted
It was @PGetaid turn to organize the 4 Nations meeting.
We had the pleasure of welcoming young GE from France, Spain, Italy, Portugal and Israel, to take part in intensive courses to deepen their knowledge of IBD. @geteccu @GEDII_IBD @IGIBD
GETAID retweeted
Great Session in #5Nations with two really inspired conferences by two leaders in infections and microbiota @yzabanaa and @h_sokol A pleasure having moderated with @fcaprioli76
GETAID retweeted
Le GETAID lance ICARE II
Objectif:évaluer en vie réelle la tolérance des nouveaux traitements des MICI
▶️ Tous les gastroentérologues en France peuvent participer
✅ Concept du patient chercheur
Formulaire d'inscription ci-dessous. On compte sur vous !
getaid.org/commission-scient…
GETAID retweeted
I think this week it’s going to be #IBD week in my #dailyGIpaper so I begin with the @PGetaid paper in anti-tng contraindications. #somosGeteccu dldjournalonline.com/article…
GETAID retweeted
⚠️ Este viernes es la fecha límite para que presentes la solicitud para acudir al 5 Nations IBD Course. ¡Aprovecha una de nuestras 11 plazas disponibles!
Más información aquí ➡️ geteccu.org/convocatoria-pla…
🇵🇹 @GEDII_IBD
🇫🇷 @PGetaid
🇮🇹 @IGIBD1
GETAID retweeted
Vient de publier une photo à Guadeloupe instagram.com/p/Clg-jKAt2HX/…
GETAID retweeted
🌟 #Israel joining Portugal @GEDII_IBD, France @PGetaid, Spain @geteccu and Italy @IGIBD for the first time in 2023!
🔮5 Nations Meeting in IBD
Want to apply? Check the link 👇 gedii.pt/_candidaturas_5_nat…
GETAID retweeted
Alimentation et MICI podcastics.com/podcast/episo…
GETAID retweeted
15 years after the first CESAME paper, the first ICARE paper is available! A unique European prospective cohort of more than 10,000 IBD patients exposed to all approved biologics. We did it! Thanks to all investigators and the @PGetaid team. More to come😊pubmed.ncbi.nlm.nih.gov/3615…





























